» Articles » PMID: 35962300

The Anti-inflammation Property of Olfactory Ensheathing Cells in Neural Regeneration After Spinal Cord Injury

Overview
Journal Mol Neurobiol
Date 2022 Aug 12
PMID 35962300
Authors
Affiliations
Soon will be listed here.
Abstract

Neural regeneration has troubled investigators worldwide in the past decades. Currently, cell transplantation emerged as a breakthrough targeted therapy for spinal cord injury (SCI) in the neurotrauma field, which provides a promising strategy in neural regeneration. Olfactory ensheathing cells (OECs), a specialized type of glial cells, is considered as the excellent candidate due to its unique variable and intrinsic regeneration-supportive properties. In fact, OECs could support olfactory receptor neuron turnover and axonal extension, which is essential to maintain the function of olfactory nervous system. Hitherto, an increasing number of literatures demonstrate that transplantation of OECs exerts vital roles in neural regeneration and functional recovery after neural injury, including central and peripheral nervous system. It is common knowledge that the deteriorating microenvironment (ischemia, hypoxia, scar, acute and chronic inflammation, etc.) resulting from injured nervous system is adverse for neural regeneration. Interestingly, recent studies indicated that OECs could promote neural repair through improvement of the disastrous microenvironments, especially to the overwhelmed inflammatory responses. Although OECs possess unusual advantages over other cells for neural repair, particularly in SCI, the mechanisms of OEC-mediated neural repair are still controversial with regard to anti-inflammation. Therefore, it is significant to summarize the anti-inflammation property of OECs, which is helpful to understand the biological characteristics of OECs and drive future studies. Here, we mainly focus on the anti-inflammatory role of OECs to make systematic review and discuss OEC-based therapy for CNS injury.

Citing Articles

Lactate promotes microglial scar formation and facilitates locomotor function recovery by enhancing histone H4 lysine 12 lactylation after spinal cord injury.

Hu X, Huang J, Li Z, Li J, Ouyang F, Chen Z J Neuroinflammation. 2024; 21(1):193.

PMID: 39095832 PMC: 11297795. DOI: 10.1186/s12974-024-03186-5.


Olfactory Ensheathing Cell Ameliorate Neuroinflammation Following Spinal Cord Injury Through Upregulating REV-ERBα in Microglia.

Zhang L, Wang L, Tan Y, Li C, Fang C Cell Transplant. 2024; 33:9636897241261234.

PMID: 39068549 PMC: 11287734. DOI: 10.1177/09636897241261234.


Interleukin-4 from curcumin-activated OECs emerges as a central modulator for increasing M2 polarization of microglia/macrophage in OEC anti-inflammatory activity for functional repair of spinal cord injury.

Guo J, Tang X, Deng P, Hui H, Chen B, An J Cell Commun Signal. 2024; 22(1):162.

PMID: 38448976 PMC: 10916222. DOI: 10.1186/s12964-024-01539-4.


OR11H1 Missense Variant Confers the Susceptibility to Vogt-Koyanagi-Harada Disease by Mediating Gadd45g Expression.

Li X, Wang G, Wang X, Li W, Li N, Liu X Adv Sci (Weinh). 2024; 11(11):e2306563.

PMID: 38168905 PMC: 10953539. DOI: 10.1002/advs.202306563.


The Promising Role of a Zebrafish Model Employed in Neural Regeneration Following a Spinal Cord Injury.

Zeng C, Tsai H Int J Mol Sci. 2023; 24(18).

PMID: 37762240 PMC: 10530783. DOI: 10.3390/ijms241813938.


References
1.
Kadomatsu K, Sakamoto K . Mechanisms of axon regeneration and its inhibition: roles of sulfated glycans. Arch Biochem Biophys. 2014; 558:36-41. DOI: 10.1016/j.abb.2014.06.009. View

2.
Yang H, He B, Hao D . Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a systematic review. Mol Neurobiol. 2014; 51(1):168-79. DOI: 10.1007/s12035-014-8664-2. View

3.
Mahar M, Cavalli V . Intrinsic mechanisms of neuronal axon regeneration. Nat Rev Neurosci. 2018; 19(6):323-337. PMC: 5987780. DOI: 10.1038/s41583-018-0001-8. View

4.
Satti H, Waheed A, Ahmed P, Ahmed K, Akram Z, Aziz T . Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study. Cytotherapy. 2016; 18(4):518-22. DOI: 10.1016/j.jcyt.2016.01.004. View

5.
Curtis E, Martin J, Gabel B, Sidhu N, Rzesiewicz T, Mandeville R . A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury. Cell Stem Cell. 2018; 22(6):941-950.e6. DOI: 10.1016/j.stem.2018.05.014. View